Cancer medicines administered orally as part of selected treatment strategies.
Oral anticancer medicines provide a treatment option for selected cancers and may allow certain therapies to be administered outside conventional infusion-based settings. Their use depends on the specific cancer, treatment objective and suitability of the individual patient.
Dr. Bhoor Singh Bhati has clinical and academic exposure to oral anticancer treatment strategies. His research includes investigation of low-dose oral metronomic therapy, contributing to his academic experience with oral approaches to systemic cancer treatment.
Drug-based cancer treatment designed to manage malignancy beyond the primary tumour.
A treatment approach using specific anticancer medicines in low doses on a planned schedule.
Using more than one therapeutic approach to address cancer through complementary treatment strategies.
Structured treatment guided by established oncology protocols and clinical evidence.
Individualised treatment planning based on cancer characteristics and patient-specific factors.
Regular evaluation of how cancer responds to treatment during the course of care.
Monitoring and managing unwanted effects associated with cancer treatment